A TLR4 antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

MD2-TLR4-I

Item No. 38328

Technical Information
Formal Name
2,6-dichloro-N-[3-(1H-indol-5-yl)-1H-indazol-5-yl]-benzamide
CAS Number
2249801-12-3
Synonyms
  • Myeloid Differentiation Factor 2-Toll-like Receptor 4-I
Molecular Formula
C22H14Cl2N4O
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 10 mg/mlDMSO: 10 mg/mlEthanol: 10 mg/ml
λmax
242 nm
SMILES
O=C(C1=C(Cl)C=CC=C1Cl)NC2=CC3=C(NN=C3C4=CC5=C(NC=C5)C=C4)C=C2
InChi Code
InChI=1S/C22H14Cl2N4O/c23-16-2-1-3-17(24)20(16)22(29)26-14-5-7-19-15(11-14)21(28-27-19)13-4-6-18-12(10-13)8-9-25-18/h1-11,25H,(H,26,29)(H,27,28)
InChi Key
AZPDJGLJPDRCDQ-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Neutrophil Biology Wall Poster

    Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.

    DOWNLOAD NOW
    Product Description

    MD2-TLR4-I is a toll-like receptor 4 (TLR4) antagonist.1 It inhibits LPS-induced production of TNF-α and IL-6 in primary mouse macrophages (IC50s = 0.89 and 0.53 µM, respectively). MD2-TLR4-I inhibits LPS-induced, TLR4-mediated NF-κB activation in a reporter assay using RAW 264.7 cells. In vivo, MD2-TLR4-I (10 mg/kg) reduces lung macrophage infiltration and prevents lung edema and alveolar thickening in a mouse model of LPS-induced acute lung injury.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Liu, Z., Chen, L., Yu, P., et alDiscovery of 3-(indol-5-yl)-indazole derivatives as novel myeloid differentiation protein 2/Toll-like receptor 4 antagonists for treatment of acute lung injury. J. Med. Chem. 62(11), 5453-5469 (2019).